Most Recent
Two former executives of mining giant Rio Tinto accused by ASIC of breaching their directors duties have asked the court to vacate an upcoming trial, after raising concerns that COVID-19 could affect their ability to appear.
Merck Sharp & Dohme has dropped a lawsuit brought against a unit of Indian generic manufacturer Lupin for allegedly threatening to infringe the patent for its multibillion-dollar diabetes drugs Januvia and Janumet.
A seven-week trial in ASIC's misleading conduct case against Rio Tinto may have to be postponed after two executives of the mining giant raised concerns that COVID-19 could impact their ability to appear as defendants in the case.
US pharmaceutical giant Merck Sharp & Dohme has taken a unit of Indian generic manufacturer Lupin to court for allegedly threatening to infringe the patent for its multibillion-dollar diabetes drugs Januvia and Janumet.
Uber has lost its latest challenge to a landmark class action that alleges the ride-sharing giant engaged in a conspiracy to steal business from taxi and limousine drivers across four states, with an appeals court dismissing arguments the case failed to properly allege an intent to harm.
Elderly victims of Ponzi schemer Bradley Sherwin have told the government's class action inquiry of their "horrendous class action journey", which led to a "pathetic outcome" in which the majority of a $12 million settlement with the Bank of Queensland went to the law firm and funder behind the case.
Uber has once again attempted to put the brakes on a landmark class action which alleges the ride-sharing giant engaged in a conspiracy to steal business from taxi and limousine drivers across four states, telling a court of appeal that the trial judge wrongly departed from prevailing laws.
US food giant Kraft-Heinz wants the High Court to hear its intellectual property stoush with Bega after twice losing the battle over the right to use its peanut butter trade dress in Australia.
A court has dismissed a claim by the Australian Government for $325 million against pharmaceutical companies Sanofi and Bristol-Myers Squibb allegedly owed for excess subsidies it paid for blood-thinner Plavix as a result of an interlocutory injunction blocking a generic version of the blockbuster drug.
A plaintiffs law firm has fired off another class action against Uber after losing a bid to amend the group definition in a class action brought against the ride-sharing giant last year.